Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Grober, Oli M V ^a   Mutarelli, Margherita ^a   Giurato, Giorgio ^a   Ravo, Maria ^a,b   Cicatiello, Luigi ^a   De Filippo, Maria R ^a   Ferraro, Lorenzo ^a   Nassa, Giovanni ^a,b   Papa, Maria F ^a   Paris, Ornella ^a   Tarallo, Roberta ^a,b   Luo, Shujun ^c   Schroth, Gary P ^c   Benes, Vladimir ^d   Weisz, Alessandro ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c ILLUMINA INC   (United States)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICRORNA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN AP2; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CHROMATIN; CONTROLLED STUDY; CYTOLOGY; ESTROGEN BINDING; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENE TARGETING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MITOCHONDRIAL GENOME; PHENOTYPE; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING;

EID: 78651370470     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-36     Document Type: Article

References (85)

1. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931. 10.1152/physrev.00026.2006, 17615392.
2. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001, 276:36869-36872. 10.1074/jbc.R100029200, 11459850.
3. Bai Z, Gust R. Breast cancer, estrogen receptor and ligands. Arch Pharm (Weinheim) 2009, 342:133-149. 10.1002/ardp.200800174, 19274700.
4. Ordonez-Moran P, Munoz A. Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 2009, 8:1675-1680.
5. Nassa G, Tarallo R, Ambrosino C, Bamundo A, Ferraro L, Paris O, Ravo M, Guzzi PH, Cannataro M, Baumann M, Nyman TA, Nola E, Weisz A. A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormoneresponsive human breast cancer cell nuclei. Proteomics
6. Tarallo R, Bamundo A, Nassa G, Nola E, Paris O, Ambrosino C, Facchiano A, Baumann M, Nyman TA, Weisz A. Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. Proteomics
7. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003, 3:281-292. 10.1124/mi.3.5.281, 14993442.
8. Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 2004, 33:387-410. 10.1677/jme.1.01541, 15525597.
9. Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 1997, 272:19858-19862. 10.1074/jbc.272.32.19858, 9242648.
10. Zhao C, Matthews J, Tujague M, Wan J, Strom A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 2007, 67:3955-3962. 10.1158/0008-5472.CAN-06-3505, 17440111.
11. Nassa G, Tarallo R, Guzzi PH, Ferraro L, Cirillo F, Ravo M, Nola E, Baumann M, Nyman TA, Cannataro M, Ambrosino C, Weisz A. Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. Mol BioSyst 2010,
12. Matthews J, Wihlén B, Tujague M, Wan J, Ström A, Gustafsson JA. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol 2006, 20:534-43. 10.1210/me.2005-0140, 16293641.
13. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000, 55:163-93.
14. Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000, 19:4970-4978. 10.1038/sj.onc.1203828, 11042684.
15. Sugiura H, Toyama T, Hara Y, Zhang Z, Kobayashi S, Fujii Y, Iwase H, Yamashita H. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Jpn J Clin Oncol 2007, 37:820-828. 10.1093/jjco/hym114, 17932113.
16. Saji S, Hirose M, Toi M. Clinical significance of estrogen receptor β in breast cancer. Cancer Chemother Pharmacol 2005, 56(Suppl 1):21-26. 10.1007/s00280-005-0107-3, 16273360.
17. Lindberg MK. Estrogen Receptor (ER)-beta Reduces ERalpha-Regulated Gene Transcription, Supporting a "Ying Yang" Relationship between ERalpha and ERbeta in Mice. Mol Endocrinol 2003, 17:203-208. 10.1210/me.2002-0206, 12554748.
18. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F. ER beta Inhibits Proliferation and Invasion of Breast Cancer Cells. Endocrinology 2001, 142:4120-4130. 10.1210/en.142.9.4120, 2040491, 11517191.
19. Behrens D, Gill JH, Fichtner I. Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells. Mol Cell Endocrinol 2007, 274:19-29. 10.1016/j.mce.2007.05.012, 17597290.
20. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen Receptor Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest. Cancer Res 2004, 64:423-428. 10.1158/0008-5472.CAN-03-2446, 14729654.
21. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006, 147:4831-4842. 10.1210/en.2006-0563, 16809442.
22. Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 2007, 9:R25. 10.1186/bcr1667, 1868918, 17428314.
23. Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson J. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008, 27:1019-1032. 10.1038/sj.onc.1210712, 17700529.
24. Fritzemeier KH, Hillisch A, Elger W, Kaufmann U, Kollenkirchen U, Kosemund D, Lindenthal B, Müller G, Muhn P, Nubbemeyer R, Peters O, Siebel P, Hegele-Hartung C. Biological effects of ERalpha- and ERbeta-selective estrogens. Ernst Schering Res Found Workshop 2004, 46:127-150.
25. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43. 10.1016/j.cell.2005.05.008, 16009131.
26. Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, Ravo M, Tarallo R, Luo S, Schroth GP, Seifert M, Zinser C, Chiusano ML, Traini A, De Bortoli M, Weisz A. Estrogen Receptor alpha Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and MicroRNAs. Am J Pathol 2010, 176:2113-2130. 10.2353/ajpath.2010.090837, 20348243.
27. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EG, Huang PY, Welboren WJ, Han Y, Ooi HS, Ariyaratne PN, Vega VB, Luo Y, Tan PY, Choy PY, Wansa KD, Zhao B, Lim KS, Leow SC, Yow JS, Joseph R, Li H, Desai KV, Thomsen JS, Lee YK, Karuturi RK, Herve T, Bourque G, Stunnenberg HG, Ruan X, Cacheux-Rataboul V, Sung WK, Liu ET, Wei CL, Cheung E, Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64. 10.1038/nature08497, 2774924, 19890323.
28. Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 2008, 456:663-666. 10.1038/nature07483, 2920208, 19005469.
29. Vivar OI, Zhao X, Saunier EF, Griffin C, Mayba OS, Tagliaferri M, Cohen I, Speed TP, Leitman DC. Estrogen receptor beta binds to and regulates three distinct classes of target genes. J Biol Chem 2010, 285:22059-22066. 10.1074/jbc.M110.114116, 20404318.
30. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA, Katzenellenbogen BS. Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol Endocrinol 2010, 24:47-59. 10.1210/me.2009-0252, 2802902, 19897598.
31. Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson JA, Dahlman-Wright K. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res 2010, 70:5174-83. 10.1158/0008-5472.CAN-09-4407, 20501845.
32. Liu Y, Gao H, Marstrand TT, Ström A, Valen E, Sandelin A, Gustafsson JA, Dahlman-Wright K. The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci USA 2008, 105:2604-2609. 10.1073/pnas.0712085105, 2268183, 18272478.
33. Ambrosino C, Tarallo R, Bamundo A, Cuomo D, Franci G, Nassa G, Paris O, Ravo M, Giovane A, Zambrano N, Lepikhova T, Jänne OA, Baumann M, Nyman TA, Cicatiello L, Weisz A. Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Mol Cell Proteomics 2010, 9:1352-1367. 10.1074/mcp.M900519-MCP200, 20308691.
34. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio C, Teti D, Bresciani F, Perillo B, Weisz A. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 2004, 24:7260-7274. 10.1128/MCB.24.16.7260-7274.2004, 479712, 15282324.
35. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 2004, 64:1522-1533. 10.1158/0008-5472.CAN-03-3326, 14973112.
36. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574. 10.1210/en.2003-0567, 12959972.
37. Buterin T, Koch C, Naegeli H. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 2006, 27:1567-1578. 10.1093/carcin/bgi339, 16474171.
38. Mardis ER. ChIP-seq: welcome to the new frontier. Nature methods 2007, 4:613-614. 10.1038/nmeth0807-613, 17664943.
39. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nussbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008, 9(9):R137. 10.1186/gb-2008-9-9-r137, 2592715, 18798982.
40. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994, 2:28-36.
41. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, Valen E, Yusuf D, Lenhard B, Wasserman WW, Sandelin A. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 2010, 38:D105-10. 10.1093/nar/gkp950, 2808906, 19906716.
42. Mahony S, Auron PE, Benos PV. DNA familial binding profiles made easy: comparison of various motif alignment and clustering strategies. PLoS Comput Biol 2007, 3:e61. 10.1371/journal.pcbi.0030061, 1848003, 17397256.
43. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008, 41:263-275. 10.1677/JME-08-0103, 2582054, 18772268.
44. Vyhlidal C, Samudio I, Kladde MP, Safe S. Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 2000, 24:329-338. 10.1677/jme.0.0240329, 10828826.
45. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999, 13:1672-1685. 10.1210/me.13.10.1672, 10517669.
46. Leung Y, Mak P, Hassan S, Ho S. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc Natl Acad Sci USA 2006, 103:13162-13167. 10.1073/pnas.0605676103, 1552044, 16938840.
47. Weigelt K, Moehle C, Stempfl T, Weber B, Langmann T. An integrated workflow for analysis of ChIP-chip data. Biotechniques 2008, 45:131-132. 134, 136 passim, 10.2144/000112819, 18687062.
48. Aulmann S, Bläker H, Penzel R, Rieker RJ, Otto HF, Sinn HP. CTCF gene mutations in invasive ductal breast cancer. Breast Cancer Res Treat 2003, 80:347-352. 10.1023/A:1024930404629, 14503807.
49. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 2008, 22:609-622. 10.1210/me.2007-0029, 2262171, 18048642.
50. Granok H, Leibovitch B, Shaffer C. Ga-ga over GAGA factor. Curr Biol 1995, 5:238-241. 10.1016/S0960-9822(95)00048-0, 7780729.
51. Van Steensel B, Delrow J, Bussemaker HJ. Genomewide analysis of Drosophila GAGA factor target genes reveals context-dependent DNA binding. Proc Natl Acad Sci USA 2003, 100:2580-2585. 10.1073/pnas.0438000100, 151383, 12601174.
52. Bauer S, Grossmann S, Vingron M, Robinson PN. Ontologizer 2.0--a multifunctional tool for GO term enrichment analysis and data exploration. Bioinformatics 2008, 24:1650-1651. 10.1093/bioinformatics/btn250, 18511468.
53. Al-Nakhle H, Burns PA, Cummings M, Hanby AM, Hughes TA, Satheesha S, Shaaban AM, Smith L, Speirs V. Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. Cancer Res 2010, 70:4778-4784. 10.1158/0008-5472.CAN-09-4104, 2883739, 20484043.
54. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 2009, 37:4850-4861. 10.1093/nar/gkp500, 2724297, 19528081.
55. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 2009, 106:15732-15737. 10.1073/pnas.0906947106, 2747188, 19706389.
56. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA Cluster 221-222 and Estrogen Receptor {alpha} Interactions in Breast Cancer. J Natl Cancer Inst 2010, 102:706-721. 10.1093/jnci/djq102, 20388878.
57. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Bénès V, Roché H, Dalenc F, Auboeuf D, Millevoi S, Vagner S. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 2009, 69:8332-8340. 10.1158/0008-5472.CAN-09-2206, 19826037.
58. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 2009, 37:2584-2595. 10.1093/nar/gkp117, 2677875, 19264808.
59. Adams BD, Guttilla IK, White BA. Involvement of microRNAs in breast cancer. Semin Reprod Med 2008, 26:522-536. 10.1055/s-0028-1096132, 18951334.
60. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
61. Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 2008, 44:2753-2759. 10.1016/j.ejca.2008.09.037, 19022662.
62. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA 2004, 101:4130-4135. 10.1073/pnas.0306948101, 384706, 15024130.
63. Chen JQ, Eshete M, Alworth WL, Yager JD. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J Cell Biochem 2004, 93:358-373. 10.1002/jcb.20178, 15368362.
64. Chen J, Russo PA, Cooke C, Russo IH, Russo J. ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta 2007, 1773:1732-1746. 10.1016/j.bbamcr.2007.05.008, 17604135.
65. Felty Q, Singh KP, Roy D. Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 2005, 24:4883-4893. 10.1038/sj.onc.1208667, 15897899.
66. Simpkins JW, Yang S, Sarkar SN, Pearce V. Estrogen actions on mitochondria--physiological and pathological implications. Mol Cell Endocrinol 2008, 290:51-59. 10.1016/j.mce.2008.04.013, 2737506, 18571833.
67. Blobel GA, Sieff CA, Orkin SH. Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 1995, 6:3147-3153.
68. Mao L, Wertzler KJ, Maloney SC, Wang Z, Magnuson NS, Reeves R. HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency. Mol Cell Biol 2009, 29:5426-5440. 10.1128/MCB.00105-09, 2756874, 19687300.
69. Massaad-Massade L, Tacine R, Dulauroy S, Reeves R, Barouki R. The functional interaction between HMGA1 and the estrogen receptor requires either the N- or the C-terminal domain of the receptor. FEBS Lett 2004, 559:89-95. 10.1016/S0014-5793(04)00032-8, 14960313.
70. Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem 1997, 272:25832-25838. 10.1074/jbc.272.41.25832, 9325313.
71. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997, 11:1486-1496. 10.1210/me.11.10.1486, 9280064.
72. Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways. Mol Cell Biol 2004, 24:7681-7694. 10.1128/MCB.24.17.7681-7694.2004, 506997, 15314175.
73. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991, 19:2499. 10.1093/nar/19.9.2499, 329467, 2041787.
74. Frezza C, Cipolat S, Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2007, 2:287-295. 10.1038/nprot.2006.478, 17406588.
75. Caporali S, Imai M, Altucci L, Cancemi M, Caristi S, Cicatiello L, Matarese F, Penta R, Sarkar DK, Bresciani F, Weisz A. Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Mol Biol Cell 2003, 14:5051-5059. 10.1091/mbc.E03-05-0303, 284806, 12960425.
76. Bermont L, Lamielle-Musard F, Chezy E, Weisz A, Adessi GL. 17beta-estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells. J Steroid Biochem Mol Biol 2001, 78:343-349. 10.1016/S0960-0760(01)00111-X, 11717004.
77. Licznar A, Caporali S, Lucas A, Weisz A, Vignon F, Lazennec G. Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor. FEBS Lett 2003, 553:445-450. 10.1016/S0014-5793(03)01090-1, 14572667.
78. Bonapace IM, Addeo R, Altucci L, Cicatiello L, Bifulco M, Laezza C, Salzano S, Sica V, Bresciani F, Weisz A. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation. Oncogene 1996, 12:753-763.
79. Cicatiello L, Scafoglio C, Altucci L, Cancemi M, Natoli G, Facchiano A, Iazzetti G, Calogero R, Biglia N, De Bortoli M, Sfiligoi C, Sismondi P, Bresciani F, Weisz A. A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J Mol Endocrinol 2004, 32:719-775. 10.1677/jme.0.0320719, 15171711.
80. Scafoglio C, Ambrosino C, Cicatiello L, Altucci L, Ardovino M, Bontempo P, Medici N, Molinari AM, Nebbioso A, Facchiano A, Calogero RA, Elkon R, Menini N, Ponzone R, Biglia N, Sismondi P, De Bortoli M, Weisz A. Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem 2006, 98:1163-1184. 10.1002/jcb.20820, 16514628.
81. Ravo M, Mutarelli M, Ferraro L, Grober OM, Paris O, Tarallo R, Vigilante A, Cimino D, De Bortoli M, Nola E, Cicatiello L, Weisz A. Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. Lab Invest 2008, 88:430-440. 10.1038/labinvest.2008.11, 18305565.
82. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942. 10.1093/bioinformatics/bti473, 15860560.
83. Ho Sui SJ, Fulton DL, Arenillas DJ, Kwon AT, Wasserman WW. oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res 2005, 33:3154-64. 10.1093/nar/gki624, 1142402, 15933209.
84. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
85. Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, Rosenbloom KR, Rhead B, Raney BJ, Pohl A, Pheasant M, Meyer L, Hsu F, Hinrichs AS, Harte RA, Giardine B, Fujita P, Diekhans M, Dreszer T, Clawson H, Barber GP, Haussler D, Kent WJ. The UCSC Genome Browser Database: update 2009. Nucleic Acids Res 2009, 37(Database issue):D755-761. 10.1093/nar/gkn875, 2686463, 18996895.